Forfivo XL FDA Approval History
FDA Approved: Yes (First approved November 10, 2011)
Brand name: Forfivo XL
Generic name: bupropion hydrochloride
Dosage form: Extended Release Tablets
Company: IntelGenx Corp.
Treatment for: Depression, Major Depressive Disorder
Forfivo XL (bupropion) is a high-strength formulation of the aminoketone antidepressant bupropion (contained in Wellbutrin) indicated for the treatment of major depressive disorder.
Development Timeline for Forfivo XL
|Nov 11, 2011||IntelGenx Announces FDA Approval of its High Dose Anti-Depressant Forfivo XL|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.